Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
Update of the Drug Resistance Mutations in HIV-1.
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome.
Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine.
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.
Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission.